According to documents submitted to the SEC, biotechnology company Avai Bio Inc and Ainnova Tech have agreed, as of May 7, 2026, to jointly terminate their previously established joint venture and related licensing agreements.

老虎证券2026/05/08 20:35

Show original

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Global gold ETF assets under management hit a record high; Institutions: Short-term pressure on gold prices does not change its long-term allocation value

新浪财经•2026/09/16 02:06

Chip shipments surge to support the foundation of foreign trade! Japan's exports achieve 12 consecutive months of steady growth

Strong demand for semiconductors drove Japan's exports to surge by 19.3% in August. However, due to high oil prices and a weaker yen, the trade deficit widened to 1.1 trillion yen.

智通财经•2026/09/16 01:36

2-Yr Benchmark Govt Yields - Germany vs Other Nations

Dow Jones•2026/09/16 01:10

10-Yr Benchmark Govt Yields - Germany vs Other Nations

Dow Jones•2026/09/16 01:10